Cardiac left ventricular hypertrophy is a risk factor for heart failure. Morphological (structural) effects such as cardiac hypertrophy can be drug-induced therefore it is important to identify these liabilities at an early stage of drug discovery and development.
In this poster, we focus on:
using HCS to detect cardiac hypertrophy
the comparison of single cell, co-culture and triculture microtissues models for predicting cardiac hypertrophy
Read our poster to learn more about our research!
Sounds interesting? Enter your details below to continue reading…
Join our community
Discover the exclusive benefits on offer if you join our community.